Mariam Zaidi
News Anchor
Trtworld
About Me
Hear My Insights
From Recognition to Regulation: Building Cyber Resilience
The rapid adoption of AI, new privacy laws, and geopolitical tensions are creating a fragmented international cybersecurity landscape, complicating enforcement and making cyber resilience and cross-border compliance difficult. As private companies become prime targets for sophisticated foreign actors, the line between corporate security and national defense has blurred. Meanwhile, organizations face increasing pressure to ensure transparency, accountability, and alignment with stringent privacy and security standards. This is no longer a technical issue—it’s a strategic one. With cybersecurity now sitting at the heart of corporate decision-making, companies must not only navigate regulatory expectations across jurisdictions but also build resilience against increasingly sophisticated cyber threats, often without a clear global framework. How can businesses better align security strategies with evolving geopolitical risks? What collaboration systems should be established to navigate regulatory complexity? In this context, how are AI and cybersecurity risks reshaping corporate decision-making and executive teams?
Trust Through Security: Reinventing Digital Identity Protection
Digital identity theft poses a direct threat to the very bedrock of our digital society. When identities are compromised, the consequences extend beyond financial losses and data breaches; they erode trust in the technological systems that underpin everything from signing contracts to transferring funds. Securing digital identities is not merely a technical necessity but a fundamental requirement to maintain confidence in the technology and the human interactions it facilitates. Implementing robust strategies—such as multi-factor authentication, biometric verification, and decentralized identity solutions—is imperative. Yet, as cyber threats grow more sophisticated, are these measures sufficient to safeguard our identities? How can we, both as individuals and organizations, stay ahead in the relentless battle against cyber adversaries and reinforce trust in our increasingly connected world?
The Quantified Self: Wearables, AI, and the Predictive Power of Personalized Data
We are living in an era where technology allows us to track and understand our bodies in unprecedented detail. Wearable devices generate a wealth of personal data, and when combined with the analytical power of AI, this information can offer profound insights into our health and well-being and empower us to make proactive choices about our lifestyle and care. How is AI transforming the raw data from wearables into actionable health intelligence? What are the latest advancements in using personalized data to predict health trends and optimize individual well-being? And how can we ensure the responsible and ethical use of this intimate information to truly empower individuals on their healthcare journey? We hear from one of the key innovators in this space on the unfolding potential of personalized health data.
AI vs. Aging: The Quest for Longevity in the Age of Machine Learning
The long-held human desire to live longer is now being supercharged by artificial intelligence: scientists are leveraging machine learning to sift through massive amounts of data, pinpoint crucial biological processes, and forecast promising ways to intervene. What fresh targets and treatment approaches are emerging from AI's analytical power? How can machine learning speed up the creation and evaluation of therapies designed to slow or even reverse aging? And what are the moral and societal questions that arise as we potentially lengthen human lifespans with these advanced technologies?
AI-Powered Drug Innovation: From Discovery to Development
AI-Powered Drug Innovation: From Discovery to Development The traditional journey of drug discovery and development is long, expensive, and fraught with uncertainty. Today, artificial intelligence is transforming this paradigm, offering the potential to significantly compress timelines across the entire spectrum, from initial target identification through preclinical studies and clinical trials. By enabling sophisticated modeling of biological systems and patient responses with exceptional precision, AI is not only accelerating the identification of promising drug candidates but also optimizing their development pathways. This session will explore what breakthroughs are already reshaping the field—and which are just around the corner. What are the strategic and regulatory hurdles to integrating these tools into an industry built on rigorous validation? And how can we harness the full promise of AI while safeguarding the trust, safety, and ethics that underpin medical innovation?